73 and 0.93.
Conclusion: By statistically eliminating the redundant items, the EMPATHIC questionnaire could be reduced from 65 to 30 items. (C) 2013 Elsevier Inc. All rights reserved.”
“Background: Unintended hyperinflation of the cuff of a laryngeal mask airway (LMA) has been associated with
increased airway morbidity and postoperative pain. While the manufacturers recommend a cuff pressure of less than 60 cmH(2)O, in usual clinical practice, there is no method used to determine intracuff pressure of an LMA. The purpose of this prospective quality assurance study is to evaluate Selleck LY3039478 the incidence of LMA hyperinflation and excessive intracuff pressure in a busy tertiary care pediatric hospital.
Methods: There was no change dictated in clinical practice for these patients. Per our usual
practice, the LMA was removed from the package and inserted with the cuff partially inflated. The cuff was further inflated as needed to ensure a seal during selleck screening library positive pressure ventilation to a peak inflating pressure of 20-25 cmH(2)O. During the first 30 min of the case, the pressure in the cuff of the LMA was measured using a hand held manometer. Additional data collected included the patient’s demographic data (age, weight, and gender), the size of the FIT, and whether nitrous oxide was in use.
Results: Of the 200 subjects in the current study, 106 had an LMA cuff pressure >= 60 cmH(2)O (53%). Patients who were greater than 8 years of age had significantly higher average cuff pressures and significantly more LMAs with an intracuff pressure >= 60 cmH(2)O when compared to patients younger than 4 years of age and patients 4-8 years of age. Similarly, larger LMAs were found to have significantly higher intracuff pressures.
Conclusions: Using current clinical practice to inflate the cuff of the LMA, a significant percentage of pediatric patients have an intracuff pressure greater than the generally recommended
upper limit of 60 cmH(2)O. Risk factors identified in our study included age of the patient and the size of the LMA. (C) 2011 Elsevier Ireland Ltd. All rights reserved.”
“Objective: To assess the effects of iron supplementation on iron status, cognitive function, affective behavior and scholastic performance in 4EGI-1 in vivo adolescents with varying iron status.
Methods: Adolescents of both sexes with varying iron status were allocated to four treatment groups by using inclusion criteria. Three of the four groups (iron deficient anemic, iron deficient and control supplement) received Iron(Ill) hydroxide polymaltose complex (IPC, Maltofer (R)) containing 100 mg of elemental iron 6 days a week for 8 months, while the fourth group (control placebo) was given a placebo. Hematological parameters, cognitive function, affective behavior and scholastic performance were assessed at baseline, 4 months and 8 months of supplementation.